The Board MOS House Group Limited announced that Dr. Lam, Lee G., BBS, JP has been appointed as an independent non-executive Director, the chairman of the corporate governance committee and a member of the audit committee and the nomination committee of the Company respectively with effect from 1 October 2023. Mr. Hui Chun Tak, PDSM has been appointed as the chairman of the remuneration committee with effect from 1 October 2023. The composition of the audit committee, the remuneration committee, the nomination committee and the corporate governance committee of the Company will be changed respectively as follows on 1 October 2023: The Audit Committee: Mr. Woo King Hang, JP (chairman); Mr. Hui Chun Tak, PDSM and Dr. Lam, Lee G., BBS, JP.

The Remuneration Committee: Mr. Hui Chun Tak, PDSM (chairman); Ms. Tsui To Fei and Mr. Woo King Hang, JP. The Nomination Committee: Mr. Simon Tso (chairman); Mr. Hui Chun Tak, PDSM and Dr. Lam, Lee G., BBS, JP. The Corporate Governance Committee: Dr. Lam, Lee G., BBS, JP (chairman); Mr. Woo King Hang, JP and Mr. Hui Chun Tak, PDSM.

Dr. Lam, Lee G., BBS, JP (Dr. Lam') has extensive international experience in general management, strategy consulting, policy advocacy, corporate governance, direct investment, investment banking and asset management. He started his career in Canada at Bell-Northern Research and Bell Canada, and later he returned to Hong Kong to serve as a general manager of Hongkong Telecom, vice president of Greater China of the international management consulting firm A.T. Kearney Inc., executive director of Singapore Technologies Telemedia Pte. Ltd., vice chairman and chief operating officer of Investment Banking Division of BOC International Holdings Limited, the chief executive officer, executive director and vice chairman of the board of Chia Tai Enterprises International Limited (now known as C.P. Lotus Corporation) of multinational conglomerate C. P. Group, senior executive vice president of C.P. Group, non-executive chairman - Hong Kong and ASEAN Region of Macquarie Infrastructure and Real Assets (Hong Kong) Limited, senior advisor - Asia, Macquarie Capital (Hong Kong) Limited, non-executive chairman - Greater China and ASEAN Region of Macquarie Infrastructure and Real Assets (Hong Kong) Limited and chief advisor - Asia of Macquarie Infrastructure and Real Assets (Hong Kong) Limited and senior advisor of Macquarie Group Asia.

Dr. Lam was Chairman of Hong Kong Cyberport, a member of the Committee on Innovation, Technology and Re-Industrialization and the Sir Murray MacLehose Trust Fund Investment Advisory Committee of the Hong Kong Special Administrative Region Government. He is a member of the Chief Executive's Policy Unit Expert Group, the Green Technology and Finance Development Committee, the Governance Committee of the Hong Kong Growth Portfolio and the Development Bureau Common Spatial Data Advisory Committee of the HKSAR Government, and convenor of the Panel of Advisors on Building Management Disputes of the HKSAR Government Home Affairs Department. He is also a Hong Kong accounting advisory expert of the PRC Ministry of Finance, a member of the Consultative Committee on Guangdong-Hong Kong Co-operation (Guangzhou Nansha), the Belt and Road and Greater Bay Area Committee of the Hong Kong Trade Development Council, and the Court of the City University of Hong Kong, chair of the United Nations Economic and Social Commission for Asia and the Pacific Sustainable Business Network, president of Hong Kong-ASEAN Economic Cooperation Foundation, chairman of the Innovation and Technology Committee of the Belt and Road General Chamber of Commerce, vice chairman of Pacific Basin Economic Council, and a board member and chairman of the Permanent Commission on Economic and Financial Issues of the World Union of Small and Medium Enterprises.

Dr. Lam holds a bachelor of science and mathematics (BSc Hons), a master of systems science and an MBA from the University of Ottawa in Canada, a post-graduate diploma in public administration from Carleton University in Canada, a post-graduate diploma in English and Hong Kong Law and an LLB (Hons) in law from Manchester Metropolitan University in the United Kingdom, a LLM in law from the University of Wolverhampton in the UK, a Postgraduate Certificate in Laws (PCLL) in law from the City University of Hong Kong, an MPA and a PhD from the University of Hong Kong. Dr. Lam is a former member of the Bar of Hong Kong, a solicitor of the High Court of Hong Kong, an accredited mediator of the Centre for Effective Dispute Resolution (CEDR), a fellow of the Hong Kong Institute of Arbitrators, the Hong Kong Institute of Directors, and Certified Management Accountants (CMA) Australia, an international affiliate of the Hong Kong Institute of Certified Public Accountants (HKICPA), an honorary fellow of Certified Public Accountants (CPA) Australia, the Hong Kong Institute of Facility Management and the University of Hong Kong School of Professional and Continuing Education, and a distinguished fellow of the Hong Kong Innovative Technology Development Association. Dr. Lam is an executive director of Hong Kong Aerospace Technology Group Limited, re-designated from non-executive director on 3 January 2022).

He is an independent non-executive director of each of CSI Properties Limited, Vongroup Limited, Mei Ah Entertainment Group Limited, Elife Holdings Limited, Haitong Securities Company Limited, Hang Pin Living Technology Company Limited, Kidsland International Holdings Limited, Greenland Hong Kong Holdings Limited and Huarong International Financial Holdings Limited, RENHENG Enterprise Holdings Limited and Sinohope Technology Holdings Limited; and a non-executive director of each of Sunwah Kingsway Capital Holdings Limited, China LNG Group Limited and Mingfa Group (International) Company Limited (re-designated from independent non-executive director on 23 April 2020). He is also an independent non-executive director of Asia-Pacific Strategic Investments Limited formerly known as China Real Estate Group Ltd.), Thomson Medical Group Limited and Alset International Limited, re-designated from non-executive director on 2 July 2020). Dr. Lam is an independent non-executive director of AustChina Holdings Limited and a non-executive director of Jade Road Investments Limited.

In the past three years, Dr. Lam was a non-executive director of National Arts Group Holdings Limited up to July 2022, Tianda Pharmaceuticals Limited up to August 2021, and China Shandong Hi-Speed Financial Group Limited up to May 2020, and he was also an independent non-executive director of Aurum Pacific (China) Group Limited up to March 2021 and Huarong Investment Stock Corporation Limited up to December 2020. He was an independent non-executive director of each of Beverly JCG Ltd. up to April 2023 and Top Global Limited up to August 2021, Sunwah International Limited up to June 2021 and TMC Life Sciences Berhad up to 31 May 2023.